Almuzaini Nujud A M, Sulieman Abdel Moneim E, Alanazi Naimah A, Badraoui Riadh, Abdallah Emad M
Department of Biology, College of Sciences, University of Hail, Hail P.O. Box 2440, Saudi Arabia.
Section of Histology-Cytology, Faculty of Medicine of Tunis, University of Tunis El Manar, La Rabta, Tunis 1007, Tunisia.
Pharmaceuticals (Basel). 2024 Dec 21;17(12):1733. doi: 10.3390/ph17121733.
In Saudi Arabia, numerous plant species with promising medicinal properties are cultivated, widely traded, and commonly utilized in traditional medicine, including fenugreek (). This study aimed to comprehensively assess the phytochemical composition and antimicrobial potential of the Saudi cultivar of fenugreek using an integrative approach combining in vitro and in silico methodologies. A comprehensive investigation was conducted on the ethanol extract of fenugreek seeds, assessing its antibacterial, antifungal, properties. Computational modeling was employed to predict pharmacokinetic behavior and potential toxicity of the identified bioactive compounds. Qalitative phytochemical analysis showed presence of alkaloids, tannins, saponins, glycosides, flavonoids, and steroids, while terpenoids were notably absent. GC-MS analysis of (fenugreek) seeds identified 25 bioactive compounds, with Ethyl methane sulfonate (12.41%) being the predominant component. Other key compounds included n-Hexadecanoic acid, 4-Butyl-2(4-nitrophenyl)-1,3-thiazole, and α-Tocopherol. In silico modeling of fenugreek phytochemicals supported their antibacterial, antioxidant, and neuroprotective potential, with compounds and showing strong binding to key targets like Tyrosyl-tRNA Synthetase (TyrRS) of (), Aspartic proteinase from () and human peroxiredoxin 5. Pharmacokinetic analysis indicated good oral bioavailability, minimal CYP inhibition, and blood-brain barrier penetration, suggesting potential for treating neurodegenerative diseases. These bioactive compounds, including diosgenin and trigonelline, support fenugreek's therapeutic promise and warrant further in vitro, in vivo, and clinical studies. The Saudi fenugreek cultivar is rich in bioactive compounds with good antibacterial potential. These findings establish a robust foundation for continued pharmacological research on the Saudi cultivar of , highlighting its potential as a rich source of bioactive compounds with significant medicinal value.
在沙特阿拉伯,许多具有潜在药用特性的植物品种被种植、广泛交易并常用于传统医学,包括葫芦巴(胡芦巴)。本研究旨在采用结合体外和计算机模拟方法的综合方法,全面评估沙特品种葫芦巴的植物化学成分和抗菌潜力。对葫芦巴种子的乙醇提取物进行了全面研究,评估其抗菌、抗真菌特性。采用计算模型预测已鉴定生物活性化合物的药代动力学行为和潜在毒性。定性植物化学分析表明存在生物碱、单宁、皂苷、糖苷、黄酮类化合物和甾体,而萜类化合物明显不存在。对葫芦巴种子的气相色谱 - 质谱分析鉴定出25种生物活性化合物,其中甲磺酸乙酯(12.41%)是主要成分。其他关键化合物包括正十六烷酸、4 - 丁基 - 2(4 - 硝基苯基)-1,3 - 噻唑和α - 生育酚。葫芦巴植物化学物质的计算机模拟模型支持其抗菌、抗氧化和神经保护潜力,化合物 和 与关键靶点如大肠杆菌的酪氨酰 - tRNA合成酶(TyrRS)、白色念珠菌的天冬氨酸蛋白酶和人过氧化物还原酶5显示出强烈结合。药代动力学分析表明口服生物利用度良好、对细胞色素P450抑制作用最小且具有血脑屏障穿透性,表明其在治疗神经退行性疾病方面具有潜力。这些生物活性化合物,包括薯蓣皂苷元和胡芦巴碱,支持葫芦巴的治疗前景,值得进一步进行体外、体内和临床研究。沙特葫芦巴品种富含具有良好抗菌潜力的生物活性化合物。这些发现为对沙特品种葫芦巴的持续药理学研究奠定了坚实基础,突出了其作为具有重要药用价值的生物活性化合物丰富来源的潜力。